Daily parenteral selenium therapy in critically ill patients: An updated systematic review and meta-analysis of randomized controlled trials

Daily parenteral selenium therapy in critically ill patients: An updated systematic review and meta-analysis of randomized controlled trials


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سید هادی ثقلینی , عطا محمودپور , مرتضی قوجازاده , میرعلی موسوی

کلمات کلیدی: Selenium Intensive care unit Parenteral Survival Hospital stay Complication

نشریه: 0 , 1 , 41 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله سید هادی ثقلینی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده پزشکی
کد مقاله 74896
عنوان فارسی مقاله Daily parenteral selenium therapy in critically ill patients: An updated systematic review and meta-analysis of randomized controlled trials
عنوان لاتین مقاله Daily parenteral selenium therapy in critically ill patients: An updated systematic review and meta-analysis of randomized controlled trials
ناشر 5
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق) Clinical Nutrition ESPEN
نوع مقاله متاآنالیز
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background and aim: Patients hospitalized at the intensive care unit (ICU) are more prone to oxidative stress. Antioxidants such as selenium (Se) may have beneficial effects on outcomes in these patients. Studies and systematic reviews in this field have inconclusive results. Methods: An updated systematic search was done to find clinical trials published in PubMed, Cochrane's library, ISI web of Science, Scopus, and Ovid databases from January 1980 up to April 2020, to assess the effects of daily Se supplementation on patient's survival, hospital and ICU stay, duration of mechanical ventilation, infection, acute renal failure (ARF) occurrence and serum creatinine levels. Results: From 1394 papers found in the first step of the search, after deleting duplicate findings, 24 studies were included in this meta-analysis. Results of the pooled random-effect size analysis of 24 trials showed no remarkable effect of daily parenteral Se administration on patient's hospital and ICU stay, duration of mechanical ventilation, infectious complications, ARF, survival and serum creatinine levels (p > 0.05). The subgroup analysis showed that daily parenteral Se administration (in doses higher than 1000 mg/d) increased the length of ICU stay by 4.48-folds (95%CI: 0.5, 9.46, p ¼ 0.07). Parenteral Se supplementation at the first and following dose of 1000 mg reduced the number of ARF at the hospitalized patients by 76% and 45%, respectively (p ¼ 0.02, and p ¼ 0.05). Conclusions: High doses of Se increases days of ICU stay, but low doses decreases the number of ARF occurrence in ICU patients. More trials are needed to assess its effect on ARF occurrence

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سید هادی ثقلینیدوم
عطا محمودپورسوم
مرتضی قوجازادهچهارم
میرعلی موسویاول

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
akhlagh.pdf1399/11/01470596دانلود
1.pdf1399/11/131961790دانلود